BASELAUNCH

BaseLaunch was initiated to help launch and grow the next generation of biotech companies. To achieve this, we collaborate closely with key players from the biotech sector, leading pharmaceutical companies, and venture funds. Our partners are Roche, Pureos Bioventures, Novo Nordisk, AbbVie, CSL, Johnson & Johnson and Bridge Biotherapeutics... We have supported 26 ventures to date. Since supporting our first ventures in early 2018, ten of our portfolio companies have, in total, raised over $800 million in financing from European and US Venture funds. Additional companies raised seed financings, several collaborations have been initiated and one company has been sold... We partner with scientists and entrepreneurs to help launch and grow exceptional biotech ventures, developing cutting-edge therapeutics.

Registration numbers: CHE-467.791.644 (W)

Primary location: Basel Switzerland